SCHEMBL21730006

SCHEMBL21730006

Oc1cc2cccc(-c3cccc4cc(O)c(O)cc34)c2cc1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM4 Q8TD43 1/20 0.50
GRIN2D O15399 1/20 0.44
GRIN2A Q12879 1/20 0.44
GRIN2B Q13224 1/20 0.44
GRIN2C Q14957 1/20 0.44
PLAU P00749 1/20 0.43
NQO2 P16083 1/20 0.43
CYP1A2 P05177 1/20 0.42
HSD17B1 P14061 5/20 0.41
HSD17B2 P37059 5/20 0.41
ESR1 P03372 2/20 0.41
ESR2 Q92731 2/20 0.41
ALOX5 P09917 1/20 0.41
TLR8 Q9NR97 1/20 0.41
ALDH1A1 P00352 3/20 0.40
HPGD P15428 2/20 0.40
TSHR P16473 1/20 0.40
MAPK1 P28482 1/20 0.40
CASP1 P29466 1/20 0.40
HIF1A Q16665 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11729402 0.85 ALDH1A1 (0.53) TRPM4GRIN2DGRIN2AGRIN2BGRIN2C
SCHEMBL7793914 0.82 GRIN2D (0.61) TRPM4GRIN2DGRIN2AGRIN2BGRIN2C
SCHEMBL7176235 0.78 CYP1A2 (0.46) TRPM4GRIN2DGRIN2AGRIN2BGRIN2C
SCHEMBL19202198 0.76 TRPM4 (0.46) TRPM4GRIN2DGRIN2AGRIN2BGRIN2C
SCHEMBL6348334 0.76 DAO (0.52) TRPM4GRIN2DGRIN2AGRIN2BGRIN2C
SCHEMBL6345832 0.76 CYP1A2 (0.54) TRPM4GRIN2DGRIN2AGRIN2BGRIN2C
SCHEMBL6346427 0.76 TRPM4 (0.46) TRPM4GRIN2DGRIN2AGRIN2BGRIN2C
SCHEMBL6349136 0.76 HSD17B1 (0.47) TRPM4GRIN2DGRIN2AGRIN2BGRIN2C
SCHEMBL10712705 0.76 ALDH1A1 (0.50) TRPM4GRIN2DGRIN2AGRIN2BGRIN2C
SCHEMBL17049622 0.75 CDK2 (0.55) TRPM4GRIN2DGRIN2AGRIN2BGRIN2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3837038-B1 DIVERSITY-ORIENTED POLYMERS OF INTRINSIC MICROPOROSITY AND USES THEREOF UNIV CALIFORNIA (US) 2023-02-15 EP disclosed
US-20210309802-A1 DIVERSITY-ORIENTED POLYMERS OF INTRINSIC MICROPOROSITY AND USES THEREOF UNITED STATES DEPARTMENT OF ENERGY 2021-10-07 US disclosed
WO-2020037246-A1 DIVERSITY-ORIENTED POLYMERS OF INTRINSIC MICROPOROSITY AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2020-02-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210309802-A1 DIVERSITY-ORIENTED POLYMERS OF INTRINSIC MICROPOROSITY AND USES THEREOF PARN, PARG, PAM TRPM4 3995/4885GRIN2D 489/4885GRIN2A 1238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.